Antigen Aggregation Decides the Fate of the Allergic Immune Response

Previously, defined naturally occurring isoforms of allergenic proteins were classified as hypoallergens and therefore suggested as an agent for immunotherapy in the future. In this paper, we report for the first time the molecular background of hypoallergenicity by comparing the immunological behavior of hyperallergenic Betula verrucosa major Ag 1a (Bet v 1a) and hypoallergenic Bet v 1d, two isoforms of the major birch pollen allergen Betula verrucosa 1. Despite their cross-reactivity, Bet v 1a and Bet v 1d differ in their capacity to induce protective Ab responses in BALB/c mice. Both isoforms induced similar specific IgE levels, but only Bet v 1d expressed relevant titers of serum IgGs and IgAs. Interestingly, hypoallergenic Bet v 1d activated dendritic cells more efficiently, followed by the production of increased amounts of Th1- as well as Th2-type cytokines. Surprisingly, compared with Bet v 1a, Bet v 1d-immunized mice showed a decreased proliferation of regulatory T cells. Crystallographic studies and dynamic light scattering revealed that Bet v 1d demonstrated a high tendency to form disulfide-linked aggregates due to a serine to cysteine exchange at residue 113. We conclude that aggregation of Bet v 1d triggers the establishment of a protective Ab titer and supports a rationale for Bet v 1d being a promising candidate for specific immunotherapy of birch pollen allergy.

[1]  P. Kalinski,et al.  The paradigm of type 1 and type 2 antigen‐presenting cells. Implications for atopic allergy , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  M. Sherman,et al.  Adjuvant potential of aggregate-forming polyglutamine domains. , 2008, Vaccine.

[3]  Manfred J. Sippl,et al.  NQ-Flipper: recognition and correction of erroneous asparagine and glutamine side-chain rotamers in protein structures , 2007, Nucleic Acids Res..

[4]  M. Totsuka,et al.  Dendritic Cells from Spleen, Mesenteric Lymph Node and Peyer's Patch Can Induce the Production of Both IL-4 and IFN-γ from Primary Cultures of Naive CD4+ T Cells in a Dose-Dependent Manner , 2003, Cytotechnology.

[5]  H. Young,et al.  Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. , 2001, The Journal of clinical investigation.

[6]  P. Briza,et al.  Isoforms of atopic allergens with reduced allergenicity but conserved T cell antigenicity: possible use for specific immunotherapy. , 1997, International archives of allergy and immunology.

[7]  K. Hoffmann‐Sommergruber,et al.  Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy , 1996, The Journal of experimental medicine.

[8]  P. Morel,et al.  Polarization of naive T cells into Th1 or Th2 by distinct cytokine‐driven murine dendritic cell populations: implications for immunotherapy , 2005, Journal of leukocyte biology.

[9]  Adam Godzik,et al.  In search for more accurate alignments in the twilight zone , 2002, Protein science : a publication of the Protein Society.

[10]  O. Majdic,et al.  The capacity of the TNF family members 4‐1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells , 2008, European journal of immunology.

[11]  K. Mathews.  Immunotherapy for allergic disease. , 1976, Comprehensive therapy.

[12]  C. Akdis,et al.  Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. , 2009, The Journal of allergy and clinical immunology.

[13]  Stephen J. Galli,et al.  The development of allergic inflammation , 2008, Nature.

[14]  M. Smulders,et al.  Seven different genes encode a diverse mixture of isoforms of Bet v 1, the major birch pollen allergen , 2006, BMC Genomics.

[15]  Motohiko Suzuki,et al.  Immune Modulation and Tolerance Induction by RelB-Silenced Dendritic Cells through RNA Interference1 , 2007, The Journal of Immunology.

[16]  J. Apold,et al.  The structural requirements of epitopes with IgE binding capacity demonstrated by three major allergens from fish, egg and tree pollen. , 1991, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[17]  P. Kalinski,et al.  Atopic allergy: a failure of antigen-presenting cells to properly polarize helper T cells? , 2000, American journal of respiratory and critical care medicine.

[18]  I. Bellinghausen,et al.  Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. , 2000, The Journal of allergy and clinical immunology.

[19]  M. Degano,et al.  Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. , 2003, Journal of molecular biology.

[20]  M. Totsuka,et al.  Dendritic Cells from Spleen, Mesenteric Lymph Node and Peyer's Patch Can Induce the Production of Both IL-4 and IFN-γ from Primary Cultures of Naive CD4+ T Cells in a Dose-Dependent Manner , 2003 .

[21]  P. Moingeon,et al.  Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-γ, and IL-17A by Naive CD4+ T Cells , 2009, The Journal of Immunology.

[22]  K. Hoffmann‐Sommergruber,et al.  Isoforms of Bet v 1, the Major Birch Pollen Allergen, Analyzed by Liquid Chromatography, Mass Spectrometry, and cDNA Cloning (*) , 1995, The Journal of Biological Chemistry.

[23]  R. Valenta,et al.  From allergen structure to new forms of allergen-specific immunotherapy. , 2002, Current opinion in immunology.

[24]  J. Saint-Remy.  Novel approaches in immunotherapy , 1994, Clinical reviews in allergy.

[25]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[26]  F. Lund-Johansen,et al.  Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides. , 2004, The Journal of allergy and clinical immunology.

[27]  C. Betzel,et al.  Dimerization of the Major Birch Pollen Allergen Bet v 1 Is Important for its In Vivo IgE-Cross-Linking Potential in Mice1 , 2005, The Journal of Immunology.

[28]  A. Ghaemmaghami,et al.  The molecular basis of allergenicity. , 2008, Trends in immunology.

[29]  Philippe Bousso,et al.  T-cell activation by dendritic cells in the lymph node: lessons from the movies , 2008, Nature Reviews Immunology.

[30]  G. Ciliberto,et al.  IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens1 , 2009, The Journal of Immunology.

[31]  S. Sakaguchi,et al.  Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. , 2009, The Journal of allergy and clinical immunology.

[32]  A. Pomés.  Allergen structures and biologic functions: The cutting edge of allergy research , 2008, Current allergy and asthma reports.

[33]  C. Radauer,et al.  Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy. , 2008, The Journal of allergy and clinical immunology.

[34]  M. Pallardy,et al.  TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation , 2009, Journal of leukocyte biology.

[35]  T. Hirano,et al.  IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation1 , 2004, The Journal of Immunology.

[36]  M. Roncarolo,et al.  Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[37]  Flemming M. Poulsen,et al.  X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy , 1996, Nature Structural Biology.

[38]  K. Hoffmann‐Sommergruber,et al.  High-level expression and purification of the major birch pollen allergen, Bet v 1. , 1997, Protein expression and purification.

[39]  Ruslan Medzhitov,et al.  A mechanism for the initiation of allergen-induced T helper type 2 responses , 2008, Nature Immunology.

[40]  T. Bieber,et al.  Dendritic cells in allergy , 1999, Allergy.

[41]  Renz,et al.  Modified T‐cell activation pattern during specific immunotherapy (SIT) in cat‐allergic patients , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  M. Herold,et al.  Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. , 2002, The Journal of allergy and clinical immunology.

[43]  R. Van Ree,et al.  Standardization of allergen products: 1. Detailed characterization of GMP‐produced recombinant Bet v 1.0101 as biological reference preparation , 2009, Allergy.

[44]  J. Schroeder,et al.  Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon‐α via toll‐like receptor 9 , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[45]  G. Casari,et al.  Modulation of IgE reactivity of allergens by site‐directed mutagenesis: potential use of hypoallergenic variants for immunotherapy , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  I. Bellinghausen,et al.  Production of interleukin‐13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription‐6 , 2003, Immunology.